
Sepse-T 1.125 Injection
Marketer
Sepik Life Sciences
Salt Composition
Cefoperazone (1000mg) + Tazobactum (125mg)
Overview Sepse-T 1.125 Injection
Sepse-T 1.125 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation and infection spread. Administration requires strict oversight by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; premature cessation can compromise efficacy. Complete the entire course of treatment, even with symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) demand prompt medical help. Inform your physician of all current medications before commencing Sepse-T 1.125 Injection therapy. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and sufficient hydration contribute to faster recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Sepse-T 1.125 Injection
Managing bacterial infections
Major Benefits of Sepse-T 1.125 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Sepse-T 1.125 Injection:
- Diarrhea
- Abnormal liver function tests
- Allergic reaction
- Anemia (low number of red blood cells)
How to use Sepse-T 1.125 Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Sepse-T 1.125 Injection works:
Sepse-T 1.125 Injection unites Cefoperazone, a bacterial growth inhibitor, and Tazobactum, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum complements this by counteracting bacterial resistance mechanisms, thus boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Sepse-T 1.125 Injection and alcohol can result in adverse effects including facial redness, tachycardia, queasiness, dehydration, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Sepse-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Sepse-T 1.125 Injection poses no known breastfeeding safety concerns. Research in humans indicates minimal to negligible drug transfer to breast milk, presenting no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
Sepse-T 1.125 Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Sepse-T 1.125 Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Sepse-T 1.125 Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sepse-T 1.125 Injection :
Should you forget a scheduled dose of Sepse-T 1.125 Injection, seek medical advice.
Facts to Know About Sepse-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
